Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells (Q38767064)

6 September 2017

title

Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells (English)

1 reference

6 September 2017

Qingxiang Yu

1

1 reference

6 September 2017

Xiaoyu Wang

2

1 reference

6 September 2017

Li Wang

3

1 reference

6 September 2017

Jia Zheng

4

1 reference

6 September 2017

Jiang Wang

5

1 reference

6 September 2017

Bangmao Wang

6

1 reference

6 September 2017

language of work or name

1 reference

2 June 2016

1 reference

Scandinavian Journal of Gastroenterology

6 September 2017

published in

1 reference

6 September 2017

volume

51

1 reference

6 September 2017

issue

10

1 reference

6 September 2017

page(s)

1220-1226

1 reference

6 September 2017

cites work

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Exploring the genomes of cancer cells: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Patterns of somatic mutation in human cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Cytogenetic and molecular aspects of gastric cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Exome Sequencing of Normal and Isogenic Transformed Human Colonic Epithelial Cells (HCECs) Reveals Novel Genes Potentially Involved in the Early Stages of Colorectal Tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

The distribution of L-asparagine synthetase in the principal organs of several mammalian and avian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Asparagine synthetase: regulation by cell stress and involvement in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Treatment of acute lymphoblastic leukaemia : a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365521.2016.1190399

10.1080/00365521.2016.1190399

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference